Source: Investing.com Stock Market ↗

Ipsen shares fall 7% after U.S. approval of generic Somatuline rival

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com Stock Market ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$86,649.06

+1.17%

ETH/USDT

$2,769.70

+1.14%

ZEC/USDT

$1,606.52

+10.44%

XRP/USDT

$1.61

+6.59%